Meeting
2018 ASCO Annual Meeting
The impact of health related quality of life (HRQoL) on short term survival of recurrent ovarian cancer patients: Analysis of pooled data from the North-Eastern German Society of Gynecological Oncology (NOGGO) meta data base.
Authors
Jalid Sehouli
AGO and Charité Campus Virchow-Klinikum, Berlin, Germany
Jalid Sehouli , Radoslav Chekerov , Maren Keller , Gulten Oskay-Oezcelik , Elena Ioana Braicu , Rolf Richter
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 5539)
DOI
10.1200/JCO.2018.36.15_suppl.5539
Abstract #
5539
Poster Bd #
266
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Predictors of stopping chemotherapy early and short survival in patients with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) who have had ≥3 lines of prior chemotherapy: The GCIG symptom benefit study (SBS).
First Author: Felicia Roncolato
Poster
2022 ASCO Annual Meeting
Association of metabolic risk factors with breast cancer survival in a population-based cohort.
First Author: Elizabeth Feliciano
Poster
2020 ASCO Virtual Scientific Program
Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study.
First Author: Mansoor Raza Mirza
Poster
2019 ASCO Annual Meeting
Response to immune checkpoint inhibition and survival in BRCA-associated recurrent ovarian cancer.
First Author: Ying L Liu